Therapeutic armamentarium for treating depression. - Test2 - elhamkhani - TriplyDB

Therapeutic armamentarium for treating depression.

Therapeutic armamentarium for treating depression.

http://www.wikidata.org/entity/Q37777008

about

A benefit-risk assessment of agomelatine in the treatment of major depression.

P2860

Q34207131-6F3806B1-5D57-472B-8B37-575B07C15761

P2860

Therapeutic armamentarium for treating depression.

http://www.wikidata.org/entity/Q37777008

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic armamentarium for treating depression.

@en

Therapeutic armamentarium for treating depression.

@nl

type

label

Therapeutic armamentarium for treating depression.

@en

Therapeutic armamentarium for treating depression.

@nl

prefLabel

Therapeutic armamentarium for treating depression.

@en

Therapeutic armamentarium for treating depression.

@nl

P1433

Q37777008-06BF20F3-75E1-4814-82BA-0AB9A23A846A

P1476

Q37777008-3CBE4659-15D5-4EA4-8103-FA72100F0041

P2860

Q37777008-0134A68B-C2C8-4C57-861D-2182A621731F

Q37777008-04647744-C6EA-433F-9BAD-7CB4AB967A1A

Q37777008-04CF39D8-E742-4CE3-803D-57A50D33B8AE

Q37777008-050F0586-BD02-41F2-9F59-B8E151C07B40

Q37777008-05B28099-7D92-4CE1-95AC-8F394E1BA14F

Q37777008-07D774A5-424C-4072-96FF-1648C6906013

Q37777008-0A8745D4-B86E-403E-AFAB-66E803FF559E

Q37777008-0C91E4AD-4573-4578-B91E-DF331AAC12C6

Q37777008-0CFE93A5-FE01-49B4-9B43-0D8F0FE69A29

Q37777008-0DF2F545-71B8-4F80-AB50-D913A72322E7

P304

Q37777008-0614B6CE-075A-4761-9BB5-FACF007B8C7D

P31

Q37777008-4BBBBF32-77CE-4DD0-9110-A8B6E3544EA1

P356

Q37777008-A5F443BD-3CA5-49BF-A690-B499D3EEDB18

P407

Q37777008-C9E70F9D-BB96-405A-B7C7-7509D064E263

P433

Q37777008-B819E683-9BCF-4641-8E40-8CD00BDDEC31

P478

Q37777008-13346914-3B82-4FAC-9124-D99E1E14508D

P50

Q37777008-61C69CBB-D33A-4E3B-B513-4191D60215F9

P577

Q37777008-901644ED-F607-4582-8EC5-212A9B5910B3

P698

Q37777008-2D36C7B9-FF9B-4B7C-87CC-44619C67B645

P356

PGM.2010.07.2176

P1433

Postgraduate Medicine

P1476

Therapeutic armamentarium for treating depression.

@en

P2860

Projections of global mortality and burden of disease from 2002 to 2030

The Efficacy of Light Therapy in the Treatment of Mood Disorders: A Review and Meta-Analysis of the Evidence

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

Depression care in the United States: too little for too few

Intensive Short-Term Dynamic Psychotherapy of treatment-resistant depression: a pilot study

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Hatha yoga for depression: critical review of the evidence for efficacy, plausible mechanisms of action, and directions for future research

Pramipexole in treatment-resistant depression: an extended follow-up

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity

Treatment of depression: time to consider folic acid and vitamin B12

P304

66-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2010.07.2176

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Robert H. Howland

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20675972

http://www.w3.org/2001/XMLSchema#string